SPC442
Ivosidenib
Status:
VeittApplication date:
4.10.2023Application published:
15.12.2023Grant published:
15.10.2025
Max expiry date:
20.1.2038Medicine name:
TibsovoMedicine for children:
No
Timeline
Today
4.10.2023Application
15.12.2023Publication
15.10.2025Registration
20.1.2038Expires
Marketing license
IS authorization number:
EU/1/23/1728Date:
30.5.2023
Foreign authorization number:
EU/1/123/1728Date:
4.5.2023
Owner
Name:
Les Laboratoires ServierAddress:
50 rue Carnot, 92284, Suresnes Cedex FR
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2804851
Deadlines
TypeDeadline until
Type: Frestur til að fara yfir drög að vottorði
Deadline until: 08.10.2025